^
Contact us  to learn more about
our Premium Content:  News alerts, weekly reports and conference planners
DRUG:

ACLX-001

i
Other names: ACLX-001, ARC-T/sparX-BCMA, SPRX001 (bivalent BCMA-specific adapter) with universal CAR-modified T cell (ARC-T cells), ARC-T/SPRX001
Company:
Arcellx, Gilead
Drug class:
BCMA-targeted CAR-T immunotherapy
Related drugs: